O-16 MELD-NA AND MELD3.0 HAVE THE BEST PERFORMANCE TO PREDICT THE 28-DAY RISK OF DEATH IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS IN THE MEXICAN POPULATION Fátima Higuera-De La Tijera; Claudia Dorantes-Nava; Alfredo Servín-Caamaño; Francisco Salas-Gordillo; Juan Miguel Abdo-Francis; Gabriela Gutiérrez-Reyes; P Diego-Salazar; MY Carmona-Castillo; Sandra Teutli-Carrion; EJ Medina-Avalos; A Servín-Higuera; José Luis Pérez-Hernández;

P-31 SHORT-TERM EFFICACY AND SAFETY OF LOLA THERAPY IN PATIENTS WITH CIRRHOSIS AND MINIMAL HEPATIC ENCEPHALOPATHY: A REAL-LIFE COHORT STUDY Fátima Higuera-De La Tijera; AB Moreno-Cobos; Christian Hinojosa-Segura; Diana Montemira-Orozco; Imran Cruz-Reyes; Juana Zavala-Ramírez; Daniel Santana-Vargas; Alfredo Servín-Caamaño; Juan Miguel Abdo-Francis; José Luis Pérez-Hernández;

O-26 ASPARTATE AMINOTRANSFERASE, AGE AND D-DIMER IN COVID-19 PATIENTS: A USEFUL PROGNOSTIC MODEL Fátima Higuera-de la Tijera; Alfredo Servín-Caamaño; Daniel Reyes-Herrera; Argelia Flores-López; Enrique J.A. Robiou-Vivero; Felipe Martínez-Rivera; Victor Galindo-Hernández; Catalina Casillas-Suárez; Oscar Chapa-Azuela; Alfonso Chávez-Morales; Víctor Hugo Rosales-Salyano; Billy Jiménez-Bobadilla; María Luisa Hernández-Medel; Benjamín Orozco-Zúñiga; Jed Raful Zacarías-Ezzat; Santiago Camacho-Hernández; José Luis Pérez-Hernández;